Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

514
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
514
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

462
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
462
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

417
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
417
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

354
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
354
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

705
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
705
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

1.2K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intra-Arterial thrombolysis after SUCCESSful angiographic recanalization in acute large-vessel occlusion stroke of the anterior circulation (IA-SUCCESS): a multicentre, randomised, clinical trial protocol.

European stroke journal·2026
Same author

Trends in prevalence and disability burden of main rheumatic and musculoskeletal diseases in France 2008-2022.

RMD open·2026
Same author

Overall effectiveness of a school-based intervention in reducing adolescents' weight status and nutritional behaviours social inequalities.

The British journal of nutrition·2026
Same author

Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study.

The Lancet. Rheumatology·2026
Same author

Safety and efficacy of direct versus conventional transfer to angiography suite in patients with severe acute stroke treated with thrombectomy (DIRECT ANGIO) in France: a multicentre, open-label, blinded-endpoint, randomised controlled trial.

The Lancet. Neurology·2026
Same author

Sante publique (Vandoeuvre-les-Nancy, France)·2026

Related Experiment Video

Updated: Feb 16, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K

Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney

Kossar Hosseini1, Abdou Y Omorou1, Jacques Hubert2

  • 1INSERM, CIC-1433 Clinical Epidemiology, CHRU Nancy, France; University of Lorraine, University Paris Descartes, EA 4360 Apemac, Nancy, France.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|December 16, 2017
PubMed
Summary

Living kidney donors experienced a significant short-term decrease in health state utility (HSU) after donation. This decline was linked to clinical complications, highlighting the importance of preventing them.

Keywords:
clinical complicationshealth state utilityliving kidney donorsminimal important decrease

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K
Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

5.7K

Related Experiment Videos

Last Updated: Feb 16, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K
Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

5.7K

Area of Science:

  • Nephrology and Transplant Surgery
  • Health Economics and Outcomes Research
  • Quality of Life Measurement

Background:

  • Living kidney donation involves assessing the donor's health status and quality of life.
  • Health State Utility (HSU) scores are crucial for evaluating the impact of medical interventions and procedures.
  • Understanding the minimal important decrease (MIDe) in HSU is vital for health economics studies.

Purpose of the Study:

  • To measure the change in HSU for living kidney donors from pre-donation to 3 months post-donation.
  • To estimate the minimal important decrease (MIDe) in HSU for living kidney donors.
  • To identify clinical factors associated with the MIDe in kidney donors.

Main Methods:

  • Prospective, multicenter observational study.
  • HSU scores measured using EuroQol five-dimensional questionnaire (EQ-5D-3L) and SF-6D.
  • MIDe derived using anchor-based and distribution-based methods; logistic regression for factor analysis.

Main Results:

  • 228 (EQ-5D-3L) and 216 (SF-6D) donors completed assessments.
  • Mean HSU scores decreased significantly from pre-donation to 3 months post-donation.
  • Anchor-based MIDe: -0.113 (EQ-5D-3L), -0.116 (SF-6D); Distribution-based MIDe: -0.075 (EQ-5D-3L), -0.077 (SF-6D).
  • Clinical complications, not surgical technique, were significantly associated with decreased HSU.

Conclusions:

  • A short-term, clinically relevant decrease in HSU is associated with clinical complications in kidney donors.
  • Preventing perioperative complications is paramount in living kidney donation to maintain donor well-being.
  • HSU changes and their determinants are important considerations for health economics evaluations in living donation.